MedTrace Logo

Acceptance-Based Treatment for Generalized Anxiety Disorder

NCT00073632 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-11-06

No results posted yet for this study

Summary

This study will develop and implement an awareness- and acceptance-based for treatment of individuals with generalized anxiety disorder.

Conditions

  • Anxiety Disorders
  • Generalized Anxiety Disorder

Interventions

BEHAVIORAL

Acceptance Based Behavioral Therapy

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of Massachusetts, Boston

    lead OTHER

Principal Investigators

  • Lizabeth Roemer, PhD · University of Massachusetts, Boston

  • Susan M Orsillo, PhD · Boston University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-05-31
Primary Completion
2006-07-31
Completion
2006-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00073632 on ClinicalTrials.gov